Blood Glucose Control in Intensive Care Patients Using the Space GlucoseControl System
Evaluation of Blood Glucose Control in Intensive Care Patients Using the Space GlucoseControl System
Glucose metabolism is impaired in many critically ill patients and is often aggravated by parenteral feeding, infections and/or pre-existent diabetes.Therefore insulin infusion protocols, which are based on frequent bedside glucose monitoring, have been implemented on most critical care units. Despite extensive efforts of the intensive care unit staff difficulties were experienced in achieving efficient and safe glucose control. Several barriers to the implementation of glycemic control have been identified. Most importantly, there is concern about increased frequency of severe hypoglycemic episodes. To overcome these problems Space GlucoseControl was developed as a decision support system which helps to achieve safe and reliable blood glucose control in the desired ranges (4.4 - 6.1 mmol/l or 4.4 - 8.3 mmol/l).
The objective of this non-interventional study is to gain additional information on the performance of the Space GlucoseControl system for glycaemic control in ICU patients when used in routine clinical practice.
研究概览
地位
条件
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Copenhagen、丹麦
- Rigshospitalet Copenhagen
-
Vejle、丹麦
- Vejle Sygehus
-
-
-
-
-
Augsburg、德国
- Klinikum
-
Leipzig、德国
- Universitatsklinikum Leipzig
-
-
-
-
-
Legnano、意大利
- Investigational Site
-
Siena、意大利
- Investigational Site
-
-
-
-
-
Hradec Kralove、捷克共和国
- Investigational Site
-
Plzen、捷克共和国
- Investigational Site
-
Prague、捷克共和国
- Investigational Sites
-
-
-
-
-
Wroclaw、波兰
- Wroclaw Medical University
-
-
-
-
-
Tartu、爱沙尼亚
- Tartu University Hospital
-
-
-
-
-
Jönköping、瑞典
- Investigational Site
-
Stockholm、瑞典
- Investigational Site
-
Södertälje、瑞典
- Investigational Site
-
-
-
-
-
Bury St Edmonds、英国
- West Suffolk Hospital
-
Truro、英国
- Royal Cornwall Hospital
-
-
-
-
-
Madrid、西班牙
- Hospital Sur,
-
-
参与标准
资格标准
适合学习的年龄
- 孩子
- 成人
- 年长者
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion:
- Intensive care patients who require blood glucose control by intravenous application of insulin
Exclusion:
- All contraindication of intravenous insulin therapy
学习计划
研究是如何设计的？
设计细节
研究衡量的是什么？
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Blood glucose values: Percentage of time within the chosen glucose target range of 4.4 - 6.1 mmol/l or 4.4 - 8.3 mmol/l
大体时间：From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Frequency of hypoglycaemic episodes
大体时间：From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
|
Adherence to the advice of the Space GlucoseControl system
大体时间：From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
|
Blood glucose measurement interval
大体时间：From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
合作者和调查者
出版物和有用的链接
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- HC-O-H-1102
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.